Literature DB >> 3014515

Human alpha-galactosidase A: nucleotide sequence of a cDNA clone encoding the mature enzyme.

D F Bishop, D H Calhoun, H S Bernstein, P Hantzopoulos, M Quinn, R J Desnick.   

Abstract

The complete nucleotide sequence has been determined for a lambda gt11 cDNA clone (lambda AG18) containing the full-length coding region for the mature lysosomal form of human alpha-galactosidase A (alpha-Gal A; EC 3.2.1.22). The lambda AG18 insert contained a 1226-base-pair sequence with an open reading frame encoding 398 amino acids of the mature polypeptide (predicted Mr = 45,356) and the last 5 amino acids of the propeptide sequence. The poly(A) signals AATACA and ATTAAA occurred 28 and 11 nucleotides prior to the TAA stop codon, respectively. There was no 3' untranslated region as the poly(A) sequence immediately followed the TAA termination codon; a second independently cloned cDNA confirmed this finding. The predicted amino acid sequence was colinear with 86 nonoverlapping residues (22% of the mature subunit) determined by microsequencing amino-terminal, tryptic, and cyanogen bromide peptides of the purified mature enzyme. Four potential N-glycosylation sites were identified, all of which occurred at predicted beta turns in hydrophilic regions of secondary structure. RNA transfer hybridization analysis of HeLa poly(A)+ RNA demonstrated a single 1.45-kilobase band whose signal was decreased by prior immunoabsorption of polysomes with monospecific alpha-Gal A antibodies. Searches of nucleic acid and protein data bases did not reveal significant homology even with the limited sequences available for mammalian lysosomal enzymes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3014515      PMCID: PMC323842          DOI: 10.1073/pnas.83.13.4859

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Transcription termination and 3' processing: the end is in site!

Authors:  M L Birnstiel; M Busslinger; K Strub
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

2.  Molecular cloning of a cDNA for human alpha-L-fucosidase.

Authors:  H Fukushima; J R de Wet; J S O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

3.  Identification of cDNA clones encoding a precursor of rat liver cathepsin B.

Authors:  B San Segundo; S J Chan; D F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

4.  Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA.

Authors:  J Sorge; C West; B Westwood; E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

5.  Cloning and sequence analysis of cDNA for human cathepsin D.

Authors:  P L Faust; S Kornfeld; J M Chirgwin
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

6.  Role of the conserved AAUAAA sequence: four AAUAAA point mutants prevent messenger RNA 3' end formation.

Authors:  M Wickens; P Stephenson
Journal:  Science       Date:  1984-11-30       Impact factor: 47.728

7.  Clusters of CpG dinucleotides implicated by nuclease hypersensitivity as control elements of housekeeping genes.

Authors:  S F Wolf; B R Migeon
Journal:  Nature       Date:  1985 Apr 4-10       Impact factor: 49.962

8.  Expression of active human factor VIII from recombinant DNA clones.

Authors:  W I Wood; D J Capon; C C Simonsen; D L Eaton; J Gitschier; B Keyt; P H Seeburg; D H Smith; P Hollingshead; K L Wion; E Delwart; E G Tuddenham; G A Vehar; R M Lawn
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

9.  Isolation and expression in Escherichia coli of a cDNA clone encoding human beta-glucuronidase.

Authors:  K S Guise; R G Korneluk; J Waye; A M Lamhonwah; F Quan; R Palmer; R E Ganschow; W S Sly; R A Gravel
Journal:  Gene       Date:  1985       Impact factor: 3.688

10.  A rapid single-stranded cloning strategy for producing a sequential series of overlapping clones for use in DNA sequencing: application to sequencing the corn mitochondrial 18 S rDNA.

Authors:  R M Dale; B A McClure; J P Houchins
Journal:  Plasmid       Date:  1985-01       Impact factor: 3.466

View more
  51 in total

1.  Purification and characterization of the recombinant Thermus sp. strain T2 alpha-galactosidase expressed in Escherichia coli.

Authors:  M Ishiguro; S Kaneko; A Kuno; Y Koyama; S Yoshida; G G Park; Y Sakakibara; I Kusakabe; H Kobayashi
Journal:  Appl Environ Microbiol       Date:  2001-04       Impact factor: 4.792

2.  Human alpha-galactosidase A: high plasma activity expressed by the -30G-->A allele.

Authors:  T F Fitzmaurice; R J Desnick; D F Bishop
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

3.  Fabry disease in a large Nova Scotia kindred: carrier detection using leucocyte alpha-galactosidase activity and an NcoI polymorphism detected by an alpha-galactosidase cDNA clone.

Authors:  A J Kirkilionis; D C Riddell; M W Spence; R G Fenwick
Journal:  J Med Genet       Date:  1991-04       Impact factor: 6.318

Review 4.  The early and late processing of lysosomal enzymes: proteolysis and compartmentation.

Authors:  A Hasilik
Journal:  Experientia       Date:  1992-02-15

5.  Translational readthrough of GLA nonsense mutations suggests dominant-negative effects exerted by the interaction of wild-type and missense variants.

Authors:  Silvia Lombardi; Mattia Ferrarese; Saverio Marchi; Paolo Pinton; Mirko Pinotti; Francesco Bernardi; Alessio Branchini
Journal:  RNA Biol       Date:  2019-10-15       Impact factor: 4.652

Review 6.  Gene therapy for Fabry disease.

Authors:  C Siatskas; J A Medin
Journal:  J Inherit Metab Dis       Date:  2001       Impact factor: 4.982

7.  Nucleotide sequences and operon structure of plasmid-borne genes mediating uptake and utilization of raffinose in Escherichia coli.

Authors:  C Aslanidis; K Schmid; R Schmitt
Journal:  J Bacteriol       Date:  1989-12       Impact factor: 3.490

8.  Cloning and high-level expression of alpha-galactosidase cDNA from Penicillium purpurogenum.

Authors:  H Shibuya; H Nagasaki; S Kaneko; S Yoshida; G G Park; I Kusakabe; H Kobayashi
Journal:  Appl Environ Microbiol       Date:  1998-11       Impact factor: 4.792

9.  Human alpha-galactosidase A: glycosylation site 3 is essential for enzyme solubility.

Authors:  Y A Ioannou; K M Zeidner; M E Grace; R J Desnick
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

10.  Monitoring the clinical and biochemical response to enzyme replacement therapy in three children with Fabry disease.

Authors:  Kevin Mills; Ashok Vellodi; Peter Morris; Donald Cooper; Michael Morris; Elisabeth Young; Bryan Winchester
Journal:  Eur J Pediatr       Date:  2004-10       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.